Pharmaceutical Executive: February 2025 Issue (PDF)

Publication
Article
Pharmaceutical ExecutivePharmaceutical Executive: February 2025
Volume 45
Issue 1

Click the title above for a link to open the Pharmaceutical Executive February 2025 issue in an interactive PDF format.

Download Issue PDF
Articles in this issue
Pharmaceutical Executive: February 2025 Issue (PDF)
Pharmaceutical Executive: February 2025 Issue (PDF)
At First Glance
At First Glance
2025 Pipeline Report: The Edge of Greatness?
2025 Pipeline Report: The Edge of Greatness?
Inclusive Marketing: Engaging with Purpose
Inclusive Marketing: Engaging with Purpose
Proactive Engagement: How AI-Driven Alerts are Transforming HCP Outreach
Proactive Engagement: How AI-Driven Alerts are Transforming HCP Outreach
The Shifting Pharmacy Landscape in 2025
The Shifting Pharmacy Landscape in 2025
Navigating the EU’s Joint Clinical Assessment
Navigating the EU’s Joint Clinical Assessment
Biopharma Business Check: Financing Review and Outlook
Biopharma Business Check: Financing Review and Outlook
Statistically and Clinically Significant Paths to Value Proposition
Statistically and Clinically Significant Paths to Value Proposition
AI: Hungry for Power
AI: Hungry for Power
Navigating Cross-Border Pharma Deals: Key Trends and Lessons Out of China
Navigating Cross-Border Pharma Deals: Key Trends and Lessons Out of China
The Teva Turnaround: Steering a Company Comeback
The Teva Turnaround: Steering a Company Comeback
Recent Videos
Kimberley Chiang, CoverMyMeds
Kimberley Chiang, CoverMyMeds
Kimberley Chiang, CoverMyMeds
Kimberley Chiang, CoverMyMeds
Kimberley Chiang, CoverMyMeds
Most Effective Strategies to Close the Innovation Gap in Women’s Health
Root Causes of Innovation Gap in Women’s Health
Fred Aslan
Gameto - Addressing Regulatory Hurdles in iPSC-Based Fertility
Related Content
Merck Reaches Licensing Agreement with Jiangsu Hengrui for Novel Heart Disease Drug

Merck Reaches Licensing Agreement with Jiangsu Hengrui for Novel Heart Disease Drug

Don Tracy, Associate Editor
March 25th 2025
Article

Under terms of the deal, Merck will gain global rights to develop, manufacture, and commercialize HRS-5346 for cardiovascular disease, excluding Greater China.

Peter Ax, UpScriptHealth

Tariffs and Drug Prices: Understanding the Impact on Pharmaceuticals

Miranda Schmalfuhs
March 24th 2025
Podcast

Peter Ax, founder & CEO of UpScriptHealth, discusses the impact of tariffs on the pharmaceutical industry and how digital health platforms could potentially help offset them.

Stock.adobe.com

USPTO Grants Notice of Allowance to Anixa Bioscience’s Ovarian Cancer Vaccine

Mike Hollan
March 25th 2025
Article

The potential vaccine is being developed in partnership with the Cleveland Clinic and the NCI.

Jennifer Butler

The Misinformation Maze: Navigating Public Health in the Digital Age

Miranda Schmalfuhs
March 11th 2025
Podcast

Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.

Pharma Pulse 3/25/25: The Unfinished Work of Healthcare Reform, Preventing Adverse Drug Events & more

Pharma Pulse 3/25/25: The Unfinished Work of Healthcare Reform, Preventing Adverse Drug Events & more

Miranda Schmalfuhs
March 25th 2025
Article

The latest news for pharma industry insiders.

The 8 Market Access Performance Metrics You Should Be Tracking

Access Infinity
March 25th 2025
Article

This guide offers an in-depth analysis of the essential KPIs that market access teams should track to measure success particularly across speed of access, breadth of access, and price performance. It includes real-life use cases and practical steps on how to get started.